Currently, there are 208.08M common shares owned by the public and among those 86.02M shares have been available to trade.
The company’s stock has a 5-day price change of 13.40% and 37.98% over the past three months. CLBT shares are trading 164.90% year to date (YTD), with the 12-month market performance up to 161.87% higher. It has a 12-month low price of $7.91 and touched a high of $22.91 over the same period. CLBT has an average intraday trading volume of 1.37 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 8.49%, 15.91%, and 52.35% respectively.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Institutional ownership of Cellebrite DI Ltd (NASDAQ: CLBT) shares accounts for 38.72% of the company’s 208.08M shares outstanding.
It has a market capitalization of $4.77B and a beta (3y monthly) value of 1.49. The earnings-per-share (ttm) stands at -$1.55. Price movements for the stock have been influenced by the stock’s volatility, which stands at 4.53% over the week and 3.63% over the month.
Earnings per share for the fiscal year are expected to decrease by -218.60%, and 118.87% over the next financial year.
Looking at the support for the CLBT, a number of firms have released research notes about the stock. Needham stated their Buy rating for the stock in a research note on March 28, 2024, with the firm’s price target at $13-$13.50. BofA Securities was of a view on February 16, 2024 that the stock is Buy, while Craig Hallum gave the stock Buy rating on July 19, 2023, issuing a price target of $11. William Blair on their part issued Mkt Perform rating on August 12, 2022.